Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder

García-Montes, José Antonio; Camacho-Castro, Anahí; Sandoval, Juan Pablo; Buendía-Hernández, Alfonso; Calderón‐Colmenero, Juan; Patiño-Bahena, Emilia; Zabal, Carlos

doi:10.1017/s1047951114000183

Cited by 15 publications

(16 citation statements)

References 8 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only one patient experienced moderate pulmonary hypertension immediately after procedure; that patient recovered after 6 months of regular treatment with bosentan. Furthermore, the LA diameter and LVEDD of all infants decreased by the 6-month follow-up and eventually returned to normal, which was consistent with the results of a previous study [5]. The ductus arteriosus is the connection between the main PA and the distal part of aortic arch; it serves as the main pathway of fetal blood circulation.…”

Section: Discussionsupporting

confidence: 90%

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Shu

Guo

Wang

et al. 2020

J Cardiothorac Surg

View full text Add to dashboard Cite

Background: Patent ductus arteriosus (PDA) is a common congenital heart disease. Interventional therapy is an important treatment for PDA. Nevertheless, few studies have investigated the safety and effectiveness of interventional therapy for infants (age, 0-36 months) with PDA and moderate-to-severe pulmonary hypertension. Therefore, this study aimed to analyze the short-term (6 months) results and interventional therapy experience for infants with PDA and moderate-to-severe pulmonary hypertension. Methods: Clinical records, echocardiographic data, and angiocardiography data of 28 infants (age, 7-36 months) who underwent interventional therapy for PDA and moderate-to-severe pulmonary hypertension between December 2011 and January 2017 at our hospital were retrospectively analyzed. All infants were treated using an Amplatzer occluder with local and deep sedation anesthesia under radiographic guidance. Results: Infants with PDA and moderate-to-severe pulmonary hypertension had poor growth. Trace residual shunts were found in two infants immediately after procedure; both had disappeared by 6 months after procedure. No significant interventional therapy-related complications occurred in the other cases. Pulmonary systolic pressure, left atrial dimension, and left ventricular end-diastolic dimension immediately after interventional therapy and 6 months later were lower than the preoperative levels (P < 0.05). The left atrial and left ventricular end-diastolic dimensions at 6 months after interventional therapy were smaller than those immediately after interventional therapy (P < 0.05). Pulmonary systolic pressure rates immediately after interventional therapy and 6 months later were not significantly different (P = 0.505). Moreover, there were no significant differences in the left ventricular ejection fraction before, immediately after, and at 6 months after interventional therapy (P = 0.628).

show abstract

Section: Discussionsupporting

confidence: 90%

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Shu

Guo

Wang

et al. 2020

J Cardiothorac Surg

View full text Add to dashboard Cite

show abstract

“…In 11 cases the initially implanted Amplatzer ductal occluder (ADO) or Amplatzer muscular ventricular septal occluder (AMVSDO) either embolised, were instable and slipped through the duct or protruded significantly into the left pulmonary artery (LPA). Devices were retrieved and changed to the Amplatzer Septal Occluder with which successful occlusion was accomplished . Thanopoulos et al describe their experience with the AMVSDO in seven patients with PAH and equivalent PDA diameters (7–13 mm) compared to our cohort.…”

Section: Discussionmentioning

confidence: 53%

“…Transcatheter closure of a patent ductus arteriosus (PDA) is performed since almost 50 years, starting with Porstmann's ivalon plug in 1967 . The interventionalist's armamentarium nowadays consists of a wide range of various occluder types and coils, mostly nitinol‐based and self‐expanding . The closing procedure itself is considered a standard procedure in most pediatric cath labs with excellent results .…”

Section: Introductionmentioning

confidence: 99%

Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech^® PDA occluder

Lehner

Ulrich

Happel

et al. 2016

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…For lager PDAs, the Amplatzer mVSD occluder is an effective choice yet, particularly for those complicated with severe pulmonary arterial hypertension. [7][8][9][10][11] The mVSD occluder manufactured in China is similar to the Amplatzer occluder. We choose the mVSD occluder because the duct in our case was large and the pulmonary pressure was high.…”

Section: Discussionmentioning

confidence: 99%

An Infectious Pseudoaneurysm Caused by Ventricular Septal Defect Occluder in Patent Ductus Arteriosus Closure in a Two-Year-Old Child

Qiu

Jin

et al. 2017

Int. Heart J.

View full text Add to dashboard Cite

SummaryWe present a case of an infectious pseudoaneurysm after patent ductus arteriosus (PDA) closure with a ventricular septal defect (VSD) occluder in a two-year-old child. The aneurysm grew rapidly but was successfully removed in time and the patient survived. To our knowledge, this is the first report of an infectious pseudoaneurysm caused by VSD occluder in PDA closure.(Int Heart J 2017; 58: 1017-1019) Key words: Aneurysmal dilatation, Infectious endocarditis, Transcatheter A neurysmal dilatation of ductus arteriosus has been considered a rare but potentially fatal abnormality. It can be either congenital or acquired as a complication of surgical ligation of patent ductus arteriosus (PDA) or after a ductal infection. And the congenital ones were much commoner than the acquired ones. In the early days, the surgical method for PDA was excision, which was replaced by occluder nowadays. There were case reports on ductus arteriosus aneurysm in PDA excision.1,2) However, to our knowledge, this is the first report of pseudoaneurysm caused by PDA occluder. Case ReportA two-year-old girl (weighing 10.5 kg) presented with a week history of cough. A physical examination revealed a continuous murmur at the second left intercostal space. Transthoracic echocardiogram revealed a PDA (Figure 1).The patient underwent right heart catheterization. A 5 French (Fr) sheath was inserted into the right femoral vein, followed by a 5-Fr MPA1 catheter, and right-sided pressures were recorded. The catheter was removed, flushed, and then inserted into the right femoral artery. The left-sided pressures were then recorded.The patient was found to have a funnel-shaped PDA (5 mm pulmonary end diameter, 13 mm aortic end diameter and 8 mm length) with preprocedural shunt and Qp:Qs of 4.1:1 (Figure 2). Right heart catheterization demonstrated a pulmonary arterial pressure of 90 mmHg/50 mmHg (mean 63 mmHg) with a mean pulmonary capillary wedge pressure of 7 mmHg. The pulmonary vessel resistance was 459 dynes sec cm-5.A 14 mm muscular ventricular septal defect (mVSD) occluder (Starway Medical Technology, China) was advanced to the site of the PDA through a 9 Fr delivery system. Its subsequent deployment closed the PDA. Postprocedural pulmonary arterial pressure was recorded as 50 mmHg/30 mmHg (mean 37 mmHg). Postoperative transthoracic echocardiogram (TTE) found no residual shunt. 0.5 g Cefazolin was given prophylactically 40 minutes before the procedure and 11.5 hours after the procedure. The postoperative examinations were normal and the patient was discharged. However, the patient came down with a fever of 40 15 days after the procedure and was transferred from a local hospital to ours. The high fever has been lasting and no response for medicines with Vancomycin and Meropenem for 2 weeks at local hospital. TTE showed that the occluder seemed to drop into the main pulmonary artery. The cardiac computed tomographic angiography revealed an aneurysmal dilatation of the ductus arteriosus with a maximum diameter of 30 mm (Figure 3, 28*30 mm). The...

show abstract

Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder

Abstract: The Amplatzer Septal Occluder is a good alternative to percutaneously treat large and hypertensive ductus arteriosus.

Cited by 15 publications

References 8 publications

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech^® PDA occluder

An Infectious Pseudoaneurysm Caused by Ventricular Septal Defect Occluder in Patent Ductus Arteriosus Closure in a Two-Year-Old Child

Contact Info

Product

Resources

About

Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder

Abstract: The Amplatzer Septal Occluder is a good alternative to percutaneously treat large and hypertensive ductus arteriosus.

Cited by 15 publications

References 8 publications

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Short-term results of interventional therapy for infants (7–36 months old) with patent ductus arteriosus and moderate-to-severe pulmonary hypertension: a retrospective study

Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech® PDA occluder

An Infectious Pseudoaneurysm Caused by Ventricular Septal Defect Occluder in Patent Ductus Arteriosus Closure in a Two-Year-Old Child

Contact Info

Product

Resources

About

Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech^® PDA occluder